Miltenyi Bioindustry Webinars
-
A Novel Cell Selective Lentiviral Platform For CAR-T Engineering
5/4/2026
Targeted lentiviral vectors enable rapid CAR‑T cell generation without extensive ex vivo manipulation. See how this approach demonstrates efficient in vitro and in vivo performance.
-
Achieving Flexibility In T Cell Manufacturing - Adaptation Of Standardized Processes
10/2/2025
Explore how scalable CAR-T manufacturing impacts T cell biology and therapy efficacy, as well as how standardized processes can support diverse production needs while preserving critical characteristics.
-
Advances In Pediatric Transplant: T-Cell Depleted Haploidentical Experience
9/11/2025
Explore how T cell–depleted haplo-HSCT is expanding donor options for pediatric patients, with insights into clinical outcomes, immune recovery, and evolving strategies.
-
Clinical-Grade Manufacturing Of Difficult-To-Transduce Cells
3/20/2025
Discover how Miltenyi R&D and Bioindustry experts revolutionize cellular therapy with BaEV-env LVVs as well as gain insights into preclinical evaluations and clinical-grade product development for CAR-NK cells.
-
Lessons Learned On Commercializing Lentiviral Vector As A Drug Substance: A Joint Roundtable With Adaptimmune And Miltenyi Bioindustry
10/1/2024
Explore how your focus and strategy must evolve as you look past clinical manufacturing, process characterization and validation methods, and quality considerations when preparing for commercial production.
-
LVV Development And Manufacturing: The Beauty Of An Established Platform Process
5/17/2024
Learn how leveraging an LVV platform can provide a fast track to GMP manufacturing, regulatory support, process characterization and validation activities to support commercialization, and more.